Seek Returns

Medpace (MEDP) Stock Analysis

This is a peer-relative look at Medpace (MEDP): its performance, risk, profitability, growth, financial strength, dividend, and valuation are each measured against its Pharmaceuticals, Biotechnology & Life Sciences peers, so every number reads in context rather than in isolation.

Company Profile

Company profile fields for Medpace (MEDP)
Profile ItemMEDP
NameMedpace Holdings, Inc.
Country/RegionUnited States
GICS SectorHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
GICS Sub-IndustryLife Sciences Tools & Services
Market Capitalization18.27 billion USD
CurrencyUSD
ExchangeNasdaq
Listing DateAugust 11, 2016
Security TypeCommon Stock

Price Performance

Cumulative Growth

MEDP
GSPC
Loading price history…
Medpace (MEDP) vs. S&P 500 (GSPC): Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Medpace (MEDP) and S&P 500 (GSPC). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Medpace (MEDP) and S&P 500 (GSPC). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Medpace (MEDP) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: MEDPIndustry group median
Total Return (1Y)13.29%24.62%
Total Return (3Y, Annualized)35.26%20.37%
Total Return (5Y, Annualized)24.49%-4.02%

Risk Profile

Drawdown History

MEDP
GSPC
Loading price history…
Medpace (MEDP) vs. S&P 500 (GSPC): Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Medpace (MEDP) and S&P 500 (GSPC). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Medpace (MEDP) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: MEDPIndustry group median
Volatility (1Y, Annualized)44.16%66.36%
Beta (5Y)1.100.93
Max Drawdown (5Y)-42.87%-80.19%

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
Each dot is a stock plotted by 1-year volatility (risk) and 1-year return. MEDP is highlighted; the dashed line is the Capital Allocation Line from the risk-free rate through the industry median — dots above it are stronger on a risk-adjusted basis.

Risk-Adjusted Metrics

Medpace (MEDP) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: MEDPIndustry group median
Sharpe Ratio (1Y)0.200.36
Sortino Ratio (1Y)0.260.58

Profitability

ROE (TTM)

Medpace (MEDP) posts ROE of 117.88%, above the industry benchmark range. Equity is being turned into profit at an exceptional rate, but very high ROE should still be checked against leverage, buybacks, and the size of the equity base.

MEDP

Pharmaceuticals, Biotechnology & Life Sciences industry group

117.88%

Group distribution
MEDP
117.88%
Max
109.18%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
Largest peers
MEDP
117.88%
LLY
86.02%
NVS
24.33%
AZN
22.57%
JNJ
20.02%
MRK
5.06%
ABBV
--
Loading chart…
Where Medpace (MEDP) stands on ROE within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Net Margin (TTM)

Medpace (MEDP) keeps 18.24% of revenue as net profit on net margin, above the industry benchmark range. That is unusually strong bottom-line conversion, though tax effects, asset sales, or other one-off gains should be checked before treating it as durable.

MEDP

Pharmaceuticals, Biotechnology & Life Sciences industry group

18.24%

Group distribution
MEDP
18.24%
Max
18.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%
Largest peers
LLY
31.90%
MEDP
18.24%
AZN
17.68%
NVS
17.49%
JNJ
16.20%
ABBV
15.67%
MRK
3.64%
Loading chart…
Where Medpace (MEDP) stands on net margin within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Operating Margin (TTM)

Medpace (MEDP) turns 23.12% of revenue into operating profit, putting operating margin in the upper peer quartile. Before financing and taxes enter the picture, the day-to-day business keeps more of each sales dollar than most industry peers.

MEDP

Pharmaceuticals, Biotechnology & Life Sciences industry group

23.12%

Group distribution
Max
83.12%
MEDP
23.12%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Largest peers
LLY
53.66%
ABBV
39.59%
MRK
35.22%
NVS
34.27%
AZN
29.57%
JNJ
25.74%
MEDP
23.12%
Loading chart…
Where Medpace (MEDP) stands on operating margin within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Profitability Metrics

Medpace (MEDP) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: MEDPIndustry group median
ROE (TTM)117.88%-26.66%
ROA (TTM)18.71%-12.50%
Net Margin (TTM)18.24%0.00%
Operating Margin (TTM)23.12%0.00%
Gross Margin (TTM)72.24%37.87%

Growth

Revenue Growth

Medpace (MEDP) grew revenue 19.97%, roughly around the peer group's normal range. Top-line momentum looks broadly typical for the industry.

Loading chart…
Medpace (MEDP): Revenue Growth across different time periods, set against Pharmaceuticals, Biotechnology & Life Sciences industry-group medians.

EPS Growth

Medpace (MEDP) grew earnings per share 20.98%, roughly around the peer group's normal range. Bottom-line momentum looks broadly typical for the industry.

Loading chart…
Medpace (MEDP): EPS Growth across different time periods, set against Pharmaceuticals, Biotechnology & Life Sciences industry-group medians.

Growth Metrics

Medpace (MEDP) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: MEDPIndustry group median
Revenue Growth (YoY)19.97%11.45%
Revenue Growth (3Y CAGR)20.12%9.94%
EPS Growth (YoY)20.98%4.28%
EPS Growth (3Y CAGR)28.04%4.17%

Financial Strength

Current Ratio (MRQ)

Medpace (MEDP) has current ratio of 0.83, in the tighter-liquidity quartile for its industry. The short-term cushion is thinner than most peers carry, even if the absolute comfort level still depends on the business model.

MEDP

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.83

Group distribution
Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
MEDP
0.83
Min
0.10
Largest peers
LLY
1.39
MRK
1.35
JNJ
1.02
AZN
1.01
NVS
0.88
ABBV
0.87
MEDP
0.83
Loading chart…
Where Medpace (MEDP) stands on current ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Debt / Equity (MRQ)

Medpace (MEDP) has debt-to-equity ratio of 0.29, roughly in line with the peer group’s normal leverage range. Its mix of debt and equity looks typical for the industry.

MEDP

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.29

Group distribution
Max
1.42
Q3
0.65
MEDP
0.29
Median
0.15
Q1
0.02
Min
0.00
Largest peers
NVS
1.29
LLY
1.23
MRK
1.20
AZN
0.66
JNJ
0.55
MEDP
0.29
ABBV
--
Loading chart…
Where Medpace (MEDP) stands on debt-to-equity ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Financial Strength Metrics

Medpace (MEDP) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: MEDPIndustry group median
Current Ratio (MRQ)0.835.52
Debt / Equity (MRQ)0.290.15
Net Debt / EBITDA-0.841.08

Dividends

Dividend Yield (TTM)

Medpace (MEDP) pays no dividend, leaving dividend yield at 0.00% this period. Shareholders may still receive value through reinvestment or buybacks, but there is no dividend income to compare here.

MEDP

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

Group distribution
MEDP
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Largest peers
NVS
2.88%
ABBV
2.40%
MRK
2.29%
JNJ
1.94%
AZN
1.73%
LLY
0.49%
MEDP
0.00%
Loading chart…
Where Medpace (MEDP) stands on dividend yield within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Dividend Payout Ratio (TTM)

Medpace (MEDP) paid no earnings out as dividends this period, leaving payout ratio at 0.00%. There is no dividend payout to size against earnings.

MEDP

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

Group distribution
MEDP
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Largest peers
MRK
343.43%
ABBV
117.35%
NVS
90.46%
JNJ
80.12%
AZN
45.38%
LLY
21.71%
MEDP
0.00%
Loading chart…
Where Medpace (MEDP) stands on payout ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Dividend Metrics

Medpace (MEDP) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: MEDPIndustry group median
Dividend Yield (TTM)0.00%0.00%
Dividend Payout Ratio (TTM)0.00%0.00%

Valuation

P/E Ratio (TTM)

Medpace (MEDP) trades at P/E ratio of 36.26, near the industry’s usual earnings multiple. The stock is not showing a clear peer discount or premium on trailing earnings.

MEDP

Pharmaceuticals, Biotechnology & Life Sciences industry group

36.26

Group distribution
Max
85.34
Q3
43.46
MEDP
36.26
Median
26.69
Q1
13.30
Min
0.07
Largest peers
MRK
148.21
ABBV
50.05
LLY
43.95
JNJ
41.92
MEDP
36.26
NVS
31.02
AZN
26.37
Loading chart…
Where Medpace (MEDP) stands on P/E ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

P/S Ratio (TTM)

Medpace (MEDP) trades at 6.44 on P/S ratio, roughly in the peer group’s normal range. The market is not making a strong cheap-or-rich statement about its revenue base.

MEDP

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.44

Group distribution
Max
58.18
Q3
25.77
Median
7.30
MEDP
6.44
Q1
3.01
Min
0.01
Largest peers
LLY
13.95
ABBV
7.80
JNJ
6.69
MEDP
6.44
MRK
5.37
NVS
5.35
AZN
4.63
Loading chart…
Where Medpace (MEDP) stands on P/S ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

P/B Ratio (MRQ)

Medpace (MEDP) trades at 31.23 on P/B ratio, above the industry benchmark range. Investors are putting an unusually rich price on each dollar of book equity relative to peers.

MEDP

Pharmaceuticals, Biotechnology & Life Sciences industry group

31.23

Group distribution
MEDP
31.23
Max
13.53
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59
Largest peers
MEDP
31.23
LLY
29.96
NVS
8.25
JNJ
8.16
MRK
8.06
AZN
5.59
ABBV
-112.34
Loading chart…
Where Medpace (MEDP) stands on P/B ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Valuation Metrics

Medpace (MEDP) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: MEDPIndustry group median
P/E Ratio (TTM)36.2626.69
P/S Ratio (TTM)6.447.30
P/B Ratio (MRQ)31.233.25
Free Cash Flow Yield (TTM)2.72%-1.66%